Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-02

Clinical Trial Update: Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule [NA]

View source ↗

Summary

The clinical trial NCT05003856 evaluating radiofrequency ablation for benign or low-risk thyroid nodules was terminated; no results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Benign Thyroid Gland Neoplasm, Recurrent Thyroid Gland Carcinoma | NA | Status: TERMINATED